Hospital Psychiatry

December, 2010 | Vol: 8 Issue: 12

In this issue

Learning Objective


Long Acting Injectable Antipsychotics: A Primer [Subscribers Only]

They used to be called “depot” antipsychotics, but the powers that be have renamed them “long acting injectables” (LAIs), presumably to help remove some of the stigma associated with their use. But no matter what you call them, suddenly every drug company is racing to introduce its own LAI neuroleptic.

Index to Volume 8, 2010 TCPR (issue:page)

An index of the topics covered in 2010

Expert QA

Treating Patients with Comorbid Medical Illness

Psychiatrists often have patients who come in bearing long lists of medications for various comorbid conditions. Is there any evidence that we should evaluate and treat such patients differently than patients without medical illnesses?

Research Update

Adding Psychosocial Interventions Can Improve Outcomes in Schizophrenia

Medication discontinuation is alarmingly common among patients with schizophrenia—it may range anywhere from 42% to 74%.

SNRIs Likely No Better than SSRIs for Depression

Due to their inhibition of both serotonin and norepinephrine reuptake, the SNRIs venlafaxine (Effexor) and duloxetine (Cymbalta) have been billed as possessing an advantage over SSRIs.

B Vitamins May Slow Brain Atrophy

Given that taking B vitamins can lower plasma homocysteine levels, a group of researchers recently examined whether supplemental B vitamins could low the rate of brain atrophy in elderly people with mild cognitive impairment (MCI).